Showing results (171-180 of 254) with videos related to
Sort By:
Pageof 26
JAMA Network Open|October 9, 2025
Clinical Significance of a Multicancer Screening Trial With Stage-Based End PointsKemal Caglar Gogebakan, Jane Lange, Lukas Owens, et al.Biostatistics (Oxford, England)|February 23, 2010
Transparency and reproducibility in data analysis: the Prostate Cancer Prevention TrialStuart G Baker, Amy K Darke, Paul Pinsky, et al.Nature Reviews. Cancer|April 3, 2003
The case for early detectionRuth Etzioni, Nicole Urban, Scott Ramsey, et al.Journal of the National Cancer Institute|March 15, 2014
Comparison of survival outcomes among cancer patients treated in and out of clinical trialsJoseph M Unger, William E Barlow, Diane P Martin, et al.Journal of the National Cancer Institute|July 4, 2002
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trendsRuth Etzioni, David F Penson, Julie M Legler, et al.JCO Precision Oncology|May 18, 2026
Impact of Multicancer Screening on Late-Stage Cancer at Diagnosis in Breast Cancer Survivors: A Modeling StudyKemal C Gogebakan, Jane Lange, Roman Gulati, et al.Journal of the National Cancer Institute|May 8, 2021
The Impact of Intensifying Prostate Cancer Screening in Black Men: A Model-Based AnalysisYaw A Nyame, Roman Gulati, Eveline A M Heijnsdijk, et al.Clinical Trials (London, England)|March 17, 2006
Evaluating markers for the early detection of cancer: overview of study designs and methodsStuart G Baker, Barnett S Kramer, Martin McIntosh, et al.Cancer|July 29, 2014
Expected population impacts of discontinued prostate-specific antigen screeningRoman Gulati, Alex Tsodikov, Ruth Etzioni, et al.Journal of the National Cancer Institute|March 30, 2026
Measuring and defining screening benefit in a new era of cancer early detectionRuth Etzioni, Kemal Gogebakan, Roman Gulati, et al.Pageof 26